Hematopoietic stem cell transplantation (HSCT) is considered a curative therapy for a number of patients suffering from certain hematological malignancies and other hematologic or immune disorders. The most favorable patient outcome occurs when the best HSCT donor is found. However, determining which donor will provide the best patient outcome is a complex decision.